1. Home
  2. BKU vs EWTX Comparison

BKU vs EWTX Comparison

Compare BKU & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BankUnited Inc.

BKU

BankUnited Inc.

HOLD

Current Price

$43.15

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$28.95

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKU
EWTX
Founded
2009
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.3B
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
BKU
EWTX
Price
$43.15
$28.95
Analyst Decision
Hold
Buy
Analyst Count
11
8
Target Price
$52.18
$37.38
AVG Volume (30 Days)
734.5K
735.0K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
3.05%
N/A
EPS Growth
14.61
N/A
EPS
3.53
N/A
Revenue
$21,732,000.00
N/A
Revenue This Year
$16.55
N/A
Revenue Next Year
$4.77
N/A
P/E Ratio
$12.29
N/A
Revenue Growth
7.45
N/A
52 Week Low
$28.21
$10.60
52 Week High
$52.11
$31.82

Technical Indicators

Market Signals
Indicator
BKU
EWTX
Relative Strength Index (RSI) 35.87 48.13
Support Level $37.36 $28.56
Resistance Level $46.92 $31.12
Average True Range (ATR) 1.26 1.46
MACD -0.24 -0.07
Stochastic Oscillator 22.42 44.71

Price Performance

Historical Comparison
BKU
EWTX

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.

Share on Social Networks: